Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halide Exchange Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1101817C reveals a cost-effective route to tetraazamacrocycles using dichloroethane and halide catalysts, offering significant supply chain advantages for MRI contrast agent precursors.